Document is current
Any future updates will be listed below
-
Authors
Zubrzycka-Sienkiewicz, Anna
Klama, Kamilla
Ullmann, Martin
Petit-Frere, Corinne
Baker, Peter
Monnet, Joëlle
Illes, Andras https://orcid.org/0009-0007-0346-8011
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04512001 at ClinicalTrials.govnct04512001 at ClinicalTrials.govDocuments that mention this clinical trial
Comparison of the efficacy and safety of a proposed biosimilar MSB11456 with tocilizumab reference product in subjects with moderate-to-severe rheumatoid arthritis: results of a randomised double-blind study
https://doi.org/10.1136/rmdopen-2023-003596
Documents that mention this clinical trial
Comparison of the efficacy and safety of a proposed biosimilar MSB11456 with tocilizumab reference product in subjects with moderate-to-severe rheumatoid arthritis: results of a randomised double-blind study
https://doi.org/10.1136/rmdopen-2023-003596
-
Funding
Funding for this research was provided by:
Fresenius Kabi SwissBioSim GmbH
- License Information
